Experimental drug drop exceeds current medications
Researchers have presented interesting results for the European League Against Rheumatism 2011 (EULAR) Congress. A medicine for gout research lesinurad was able to get a rapid and sustained reduction in urate levels in gout patients who did not receive the desired results with uric acid-lowering drugs used. “Lesinurad, an inhibitor of the URAT1 increases urinary […]